| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2001 | US20010014311 External preparation for skin |
| 08/16/2001 | EP1144678A3 Susceptibility to psoriasis |
| 08/16/2001 | EP1144373A3 Serine protease inhibitors |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/16/2001 | EP1123933A1 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
| 08/16/2001 | EP1123931A1 Tricylic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 08/16/2001 | EP1123927A1 Process for the preparation of bis-(4-amino-1-pyridinium)-alkanes |
| 08/16/2001 | EP1123926A1 Piperazine derivatives for treatment of CNS disorders |
| 08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
| 08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
| 08/16/2001 | EP1123922A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/16/2001 | EP1123717A2 Estrogen agonist/antagonist and statin containing compositions for treating osteoporosis and lowering cholesterol |
| 08/16/2001 | EP1123708A1 Tear grass-derived antibacterial agent and process for producing the same |
| 08/16/2001 | EP1123705A1 Pharmaceutical combinations for treating lower urinary tract disfunctions |
| 08/16/2001 | EP1123704A1 Remedies for spinal canal stenosis |
| 08/16/2001 | EP1123703A1 Immunomodulatory drug composition |
| 08/16/2001 | EP1123702A1 Analgesics |
| 08/16/2001 | EP1123701A1 Natural physiologically active substances efficacious against fish diseases and fish feeds containing the same |
| 08/16/2001 | EP1123700A1 Timed pulsatile drug delivery systems |
| 08/16/2001 | EP1123699A2 Tablet and process for making the same |
| 08/16/2001 | EP1123414A1 Antisense modulation of integrin alpha 4 expression |
| 08/16/2001 | EP1123397A2 G-protein coupled receptors |
| 08/16/2001 | EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123385A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 08/16/2001 | EP1123308A1 Single morphic forms of known peptide metalloproteinase inhibitors |
| 08/16/2001 | EP1123304A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 08/16/2001 | EP1123297A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123295A1 Bicyclic nitrogen heterocycles |
| 08/16/2001 | EP1123294A1 Novel pterin antineoplastic agents |
| 08/16/2001 | EP1123292A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123288A1 Vitreous form of known bradykinin antagonist |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123284A1 Method for the preparation of citalopram |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123280A1 Serine protease inhibitor |
| 08/16/2001 | EP1123279A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123278A1 Method for producing (+)-exo-6-phenyl-3-azabicyclo- 3.2.0]heptanes |
| 08/16/2001 | EP1123277A1 Epibatidine analogues as acetylcholine receptor antagonists |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1123269A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123267A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123120A1 Medicinal aerosol formulation |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123113A1 Ribozymes used as prodrugs |
| 08/16/2001 | EP1123111A1 Modulation of gene expression by combination therapy |
| 08/16/2001 | EP1123110A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 08/16/2001 | EP1123106A1 Composition containing eugenol and polyphenols and use of such a composition for wound healing |
| 08/16/2001 | EP1123104A1 Inherently antimicrobial quaternary amine hydrogel wound dressings |
| 08/16/2001 | EP1123103A1 A process for producing an iron-dextran compound |
| 08/16/2001 | EP1123102A1 Method of preventing acute lung injury |
| 08/16/2001 | EP1123101A1 Fluticasone lotion having improved vasoconstrictor activity |
| 08/16/2001 | EP1123100A1 Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof |
| 08/16/2001 | EP1123099A1 Novel indenoisoquinolines as antineoplastic agents |
| 08/16/2001 | EP1123098A1 Method for treating hot flashes in humans |
| 08/16/2001 | EP1123097A1 Pharmaceutical composition containing decursin |
| 08/16/2001 | EP1123096A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 08/16/2001 | EP1123095A1 Pharmaceutical formulations useful to treat inflammatory and immune disorders |
| 08/16/2001 | EP1123094A1 Therapeutic compositions (ii) |
| 08/16/2001 | EP1123093A1 Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same |
| 08/16/2001 | EP1123092A2 Fumaric acid microtablets |
| 08/16/2001 | EP1123091A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 08/16/2001 | EP1123090A1 Method and composition for modulating amyloidosis |
| 08/16/2001 | EP1123088A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 08/16/2001 | EP1123087A1 Oral pulsed dose drug delivery system |
| 08/16/2001 | EP1123085A1 O/w emulsion comprising an hydroxylated oil |
| 08/16/2001 | EP1123084A1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients |
| 08/16/2001 | EP1123082A1 Preparations for topical application of substances having antiandrogenic effect |
| 08/16/2001 | EP1123072A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/16/2001 | EP1123008A2 Preparation and use of solidified oils |
| 08/16/2001 | EP1066292A4 Metallocorrinoids as biologically compatible carriers of pharmacological agents |
| 08/16/2001 | EP1037597B1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 08/16/2001 | EP1035851B1 Endothelin receptor antagonists for combating hyperlipidaemia |
| 08/16/2001 | EP1007006A4 Cefadroxil monohydrate tablet formulation |
| 08/16/2001 | EP0964681B1 Anticonvulsant derivatives useful in treating psoriasis |
| 08/16/2001 | EP0944388A4 Inhibitors of farnesyl-protein transferase |
| 08/16/2001 | EP0939635B1 Improved intraocular irrigating solution containing a polyamine antagonist |
| 08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 08/16/2001 | EP0885208B1 Taxoids, their preparation and pharmaceutical compositions containing them |
| 08/16/2001 | EP0882033B1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 08/16/2001 | EP0874838B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 08/16/2001 | EP0839137B1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 08/16/2001 | EP0828715B1 N-oxides as antibacterial agents |
| 08/16/2001 | EP0825972B1 Novel ether compound and process for producing the same |
| 08/16/2001 | EP0812199A4 Sphingosine, methylsphingosine and apoptosis |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/16/2001 | EP0788498B1 Phenyloxazolidinone antimicrobials |
| 08/16/2001 | EP0771189B1 Inhalation composition |
| 08/16/2001 | EP0768876B1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 08/16/2001 | EP0765329B1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 08/16/2001 | EP0748626B1 Patch containing isosorbide dinitrate and prepared by using adhesive mixture |
| 08/16/2001 | EP0733045B1 4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors |
| 08/16/2001 | EP0725634B1 Plaster for the treatment of nail mycoses |
| 08/16/2001 | EP0706380B1 Encapsulated medicine |